|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Hypersomnia | |||||
| Narcolepsy | |||||
| Nervous System Disease | |||||
| Sleep Disorder | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Disease | |||||
| Disorders of Excessive Somnolence | |||||
| Nervous System Diseases | |||||
| Sleep Disorders | |||||
| 3 | More general conditions related to this trial | ||||
| Dyssomnias | |||||
| Mental Disorders | |||||
| Neurologic Manifestations | |||||
| Pathologic Processes | |||||
| Signs and Symptoms | |||||
| Sleep Disorders, Intrinsic | |||||
| 4 | Sponsors listed in this trial | ||||
| National Institute of Neurological Disorders and Stroke (NINDS) | |||||